4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-447899
President, Oncology sold 8,333 shares at an average $80.89 ($674,069)
- President, Oncology acquired 8,333 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Vieira Roberto Wandenkolk · President, Oncology
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,333 | $21.63 | $180,243 | 12,279 | D |
| 2026-11-02 | Sale : show line 2 in the form 10b5-1 | −6,657 | $80.73 | $537,437 | 5,622 | D |
| 2026-11-02 | Sale : show line 3 in the form 10b5-1 | −1,676 | $81.52 | $136,632 | 3,946 | D |
| Open-market sales · 8,333 sh · avg $80.89 · $674,069 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 4 in the form 10b5-1 Stock option (right to buy) | −8,333 | 125,001 | D |
Loading xslF345X06/ownership.xml…